India, US sign pact on 3D bioprinting, regenerative medicine

The collaboration between India and the US in the field of 3D bioprinting and regenerative medicine that aims to restore the normal functioning of damaged body organs by rebuilding the lost tissues, has got the official backing this month.
The Government stamped its approval to research pact between Sree Chitra Tirunal Institute for Medical Sciences and Technology, Trivandrum, and Institute for Regenerative Medicine (WFIRM), North Carolina, signed in December last year.
Cabinet headed by Prime Minister Narendra Modi gave an “ex-post facto approval to the inter-institutional Agreement between India and the USA in the areas of regenerative medicine and 3D bioprinting,” a statement here said.
The government also gave a go-ahead to new technologies, exchange of scientific ideas and technologies, and joint use of scientific infrastructure under the agreement.
The Ministry of Science &Technology said the joint research projects, training programmes, conferences, and seminars under the agreement will be open to all qualified scientists and technologists, and will be supported on the basis of scientific merit and excellence.
There will be exchange of faculty members and students for training, study and research especially in the areas on 3D Bioprinting, execution of joint research projects, it said.
Scientific research and technology development in the areas of regenerative medicine and 3D bio-printing will have potential for generation of new intellectual property, processes, prototypes or products.
The Government says the objective of the agreement is to contribute towards the development of research and education of both the Institutions through academic collaboration.

Leave a Reply